Andreas Betz

机构：Heidelberg University, Unit of Virus Host Cell Interactions, University Hospital Heidelberg · ORCID：0000-0001-6115-1812

发表论文 18 篇 · 总被引 387 次 · h-index 7

代表论文

Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis (2011 · Journal of Pharmacology and Experimental Therapeutics · 被引 117)
The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer (2014 · Journal of Pharmacology and Experimental Therapeutics · 被引 92)
The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia (2012 · Journal of Pharmacology and Experimental Therapeutics · 被引 54)
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies (2018 · Clinical Cancer Research · 被引 40)
Efficacy of the Novel Selective Platelet-Derived Growth Factor Receptor Antagonist CT52923 on Cellular Proliferation, Migration, and Suppression of Neointima following Vascular Injury (2001 · Journal of Pharmacology and Experimental Therapeutics · 被引 39)
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers (2016 · The Journal of Clinical Pharmacology · 被引 19)